Midgard Science

Labs / Assays & in vitro testing

I

Invenra

Madison, WI, United States · invenra.com

Invenra develops and characterizes monoclonal, bispecific, and trispecific antibodies for drug discovery and development. It works with biotech and other research teams on discovery, expression, validation, and partnership programs, based in Madison, Wisconsin, United States.

They take quote requests through a form on their website with project details. Their quote form

What they offer

  • Monoclonal antibody discovery

    Produces fully human mAb leads with binding properties, developability data, and functional validation.

  • B-Body bispecific discovery

    Screens bispecific combinations in final therapeutic format and delivers lead candidates ready for cell line development.

  • B-Body bispecific expression

    Expresses and purifies customer-provided sequences as B-Body bispecific antibodies.

  • T-Body trispecific discovery

    Develops trispecific antibody candidates for three-target engagement in a custom partnership model.

  • Characterization and validation

    Provides functional immunology, biophysical developability, and binding data for molecules at any stage.

  • ADC program support

    Supports antibody-drug conjugation-compatible platform work and ADC-related development.

What they work on

Modalities
Antibody, Bispecific, ADC
Species and models
human phage libraries, CHO cells
Assays and studies
cross-reactivity testing, affinity (KD) measurements, cell-based functional screening, binding kinetics, epitope diversity, validated cell binding analysis, in silico liability scanning, mass spectrometry intact mass confirmation, developability assays, formulation optimization, thermal stability, self-association, and 3 more
Instruments and platforms
Carterra LSA
Scale and capacity
30+ proprietary human phage libraries, 288+ bispecific combinations, 50 mL expression, 200 mL expression, 500 mL expression
Therapeutic areas
cancer, immuno-oncology
Turnaround
≤ 12 wks · 4 months from binder to lead candidates · 4-8 weeks from DNA to purified antibody
What to send
antigen · purified recombinant antigens · cell lines · VH/VL sequences for each binding arm · target biology and program goals
Minimums and prices
$100K starting price for mAb Discovery · $200K starting price for B-Body Discovery · $3,750 per molecule for B-Body Expression
Type
CRDMO
Sites
Madison, United States
Address
5510 Element Way Suite 400 Madison, WI 53719

Similar labs. Sparx BIO, AbTherx, Aurigene Pharmaceutical Services, GlycoNex, Inc.

Found in a contract services directory. Listing built from invenra.com. Work here? Claim this listing.

Invenra · Midgard Science